Brainstorm Cell Therapeutics Inc. (BCLI) jumped 5.13% or 0.16 to $3.28. It is approximately 32185 shares traded, which is 55.79% compare to the average total volume 57693. The market cap of BCLI is $67.90 million. The year to date change is -9.39%. The 52 week price range is from $2.88 to $5.35. Price of BCLI have changed -3.70% during last week. It have changed -19.59% over last month, -26.93% over last 3 months, -8.24% over last 6 months and -27.27% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.78. It is 15.24% above current price. The 200-day Moving Averages for BCLI is 3.75. It is 14.33% above current price. The 52-week High is 5.35. It is 63.11% from the current price. The 52-week Low is 2.88. It is -12.20% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 22.52 on 2018-10-15. Short % to float is 6.72%. There are some statistics of BCLI. It is has market cap $67.90 million. The share outstanding is 20.70 million. The average volume is 57693. The percent of top 15 Institution holding is 7.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -74.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -51.80%.